02838: Standardization of rLiNTPDase2 and Derived Chimeras as Antigens on Immunochromatographic Assay for Diagnosis of Canine Visceral Leishmaniasis

Grant Status: Open

Grant Amount: $41,040
Juliana Fietto, PhD; Federal University of Viçosa
April 1, 2021 - March 31, 2023

Sponsor(s): Golden Retriever Foundation®

Breed(s): -All Dogs
Research Program Area: Immunology and Infectious Disease
Donate to Support this Research Program Area

One Health: Yes


Canine visceral leishmaniasis (CVL) corresponds to the most aggressive and lethal form of leishmaniasis manifesting in dogs. In North, Central and South America, CVL is caused by Leishmania infantum and diagnostic techniques currently used to identify infected animals have important limitations in sensitivity and specificity. The main goal of this study is to develop new and accessible technologies for CVL diagnosis based on more specific antigens. This accomplishment has high potential to create a positive impact on diagnostic strategies all over the globe and to increase the amount of correctly diagnosed and treated dogs.


None at this time.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Connect With Us:
Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617

Tax ID# 13-3813813

   2020 GuideStar logo

© 2020 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software